Obstructive Sleep Apnea Causes Oxidative Damage to Plasma Lipids and Proteins and Decreases Adiponectin Levels

Overview

Journal Sleep Breath

Publisher Springer

Date 2010 Jun 22

PMID 20563658

Citations 43

Authors

Ebru Vatansever

Esma Surmen-Gur

Ahmet Ursavas

Mehmet Karadag

Affiliations

Soon will be listed here.

Abstract

Unlabelled: PUPOSE: Obstructive sleep apnea (OSA) is associated with various metabolic disorders, and oxidative stress was suggested to play an important role. In the present study, we aimed to investigate serum adiponectin and oxidative stress markers, especially protein carbonyls, and to evaluate the correlation between these parameters and lipid, insulin and fasting glucose concentrations in OSA patients and controls.

Method: Blood was drawn from healthy male volunteers following full-night polysomnographic evaluation. Subjects were classified as controls (n = 24), mild OSA group (n = 9) and moderate-severe OSA group (n = 17) according to their apnea-hypopnea indices (AHIs). Serum lipids, fasting glucose, adiponectin, malondialdehyde (MDA), protein carbonyl concentrations, and paraoxonase activities were measured in all subjects.

Results: Results of this study indicated that serum adiponectin concentrations were significantly decreased and MDA and protein carbonyl concentrations were significantly elevated in OSA patients compared to the controls. Protein carbonyl and MDA concentrations were significantly and positively correlated with AHI, while a significant negative correlation was found between adiponectin concentrations and AHI. Adiponectin levels were negatively correlated with MDA levels.

Conclusion: Results of this study, which is the first human study investigating and describing serum protein carbonyl concentrations in OSA patients, reveal that OSA causes increments in oxidative damage and decreases adiponectin levels. The recurrent hypoxia-reoxygenation attacks in OSA patients may activate oxidative stress, elevating sympathetic activity and leading to low levels of adiponectin.

Citing Articles

Influence of Obstructive Sleep Apnea on Oxidative Stress in Pregnancy.

Canaves-Gomez L, Gimenez Carrero M, Alvarez Ruiz De Larrinaga A, Sanchez Baron A, Codina Marcet M, Iglesias Coma A Int J Mol Sci. 2025; 26(3).

PMID: 39940656 PMC: 11817803. DOI: 10.3390/ijms26030886.

Unveiling the molecular and cellular links between obstructive sleep apnea-hypopnea syndrome and vascular aging.

Liu W, Zhang L, Liao W, Liu H, Liang W, Yan J Chin Med J (Engl). 2024; 138(2):155-171.

PMID: 39647991 PMC: 11745861. DOI: 10.1097/CM9.0000000000003352.

Intermittent hypoxia: linkage between OSAS and epilepsy.

Ma Y, Wu Q Front Pharmacol. 2023; 14:1230313.

PMID: 38074156 PMC: 10701596. DOI: 10.3389/fphar.2023.1230313.

Obstructive Sleep Apnea and Stroke: Determining the Mechanisms Behind their Association and Treatment Options.

Mohamed B, Yarlagadda K, Self Z, Simon A, Rigueiro F, Sohooli M Transl Stroke Res. 2023; 15(2):239-332.

PMID: 36922470 DOI: 10.1007/s12975-023-01123-x.

Cardiovascular Disease in Obstructive Sleep Apnea: Putative Contributions of Mineralocorticoid Receptors.

Badran M, Bender S, Gozal D Int J Mol Sci. 2023; 24(3).

PMID: 36768567 PMC: 9916750. DOI: 10.3390/ijms24032245.

References

Bruun J, Lihn A, Verdich C, Pedersen S, Toubro S, Astrup A . Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans. Am J Physiol Endocrinol Metab. 2003; 285(3):E527-33. DOI: 10.1152/ajpendo.00110.2003. View

Sonka K, Fialova L, Volna J, Jiroutek P, Vavrova J, Kemlink D . Advanced oxidation protein products in obstructive sleep apnea. Prague Med Rep. 2009; 109(2-3):159-65. View

Trujillo M, Scherer P . Adiponectin--journey from an adipocyte secretory protein to biomarker of the metabolic syndrome. J Intern Med. 2005; 257(2):167-75. DOI: 10.1111/j.1365-2796.2004.01426.x. View

Itzhaki S, Dorchin H, Clark G, Lavie L, Lavie P, Pillar G . The effects of 1-year treatment with a herbst mandibular advancement splint on obstructive sleep apnea, oxidative stress, and endothelial function. Chest. 2007; 131(3):740-749. DOI: 10.1378/chest.06-0965. View

Banno K, Kryger M . Sleep apnea: clinical investigations in humans. Sleep Med. 2007; 8(4):400-26. DOI: 10.1016/j.sleep.2007.03.003. View

Punjabi N, Shahar E, Redline S, Gottlieb D, Givelber R, Resnick H . Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study. Am J Epidemiol. 2004; 160(6):521-30. DOI: 10.1093/aje/kwh261. View

Fantuzzi G . Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol. 2005; 115(5):911-9. DOI: 10.1016/j.jaci.2005.02.023. View

Ip M, Lam B, Ng M, Lam W, Tsang K, Lam K . Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med. 2002; 165(5):670-6. DOI: 10.1164/ajrccm.165.5.2103001. View

Carpagnano G, Kharitonov S, Resta O, Foschino-Barbaro M, Gramiccioni E, Barnes P . 8-Isoprostane, a marker of oxidative stress, is increased in exhaled breath condensate of patients with obstructive sleep apnea after night and is reduced by continuous positive airway pressure therapy. Chest. 2003; 124(4):1386-92. DOI: 10.1378/chest.124.4.1386. View

10.

Saarelainen S, Lehtimaki T, Poussa T, Nikkila M, Solakivi T, Nieminen M . Autoantibodies against oxidised low-density lipoprotein in patients with obstructive sleep apnoea. Clin Chem Lab Med. 1999; 37(5):517-20. DOI: 10.1515/CCLM.1999.083. View

11.

Arnardottir E, Mackiewicz M, Gislason T, Teff K, Pack A . Molecular signatures of obstructive sleep apnea in adults: a review and perspective. Sleep. 2009; 32(4):447-70. PMC: 2663860. DOI: 10.1093/sleep/32.4.447. View

12.

Jordan W, Berger C, Cohrs S, Rodenbeck A, Mayer G, Niedmann P . CPAP-therapy effectively lowers serum homocysteine in obstructive sleep apnea syndrome. J Neural Transm (Vienna). 2004; 111(6):683-9. DOI: 10.1007/s00702-004-0130-2. View

13.

Soares A, Guichardant M, Cozzone D, Bernoud-Hubac N, Bouzaidi-Tiali N, Lagarde M . Effects of oxidative stress on adiponectin secretion and lactate production in 3T3-L1 adipocytes. Free Radic Biol Med. 2005; 38(7):882-9. DOI: 10.1016/j.freeradbiomed.2004.12.010. View

14.

Tanriverdi H, Evrengul H, Kuru O, Tanriverdi S, Seleci D, Enli Y . Cigarette smoking induced oxidative stress may impair endothelial function and coronary blood flow in angiographically normal coronary arteries. Circ J. 2006; 70(5):593-9. DOI: 10.1253/circj.70.593. View

15.

McArdle N, Hillman D, Beilin L, Watts G . Metabolic risk factors for vascular disease in obstructive sleep apnea: a matched controlled study. Am J Respir Crit Care Med. 2006; 175(2):190-5. DOI: 10.1164/rccm.200602-270OC. View

16.

Matthews D, Hosker J, Rudenski A, Naylor B, Treacher D, Turner R . Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985; 28(7):412-9. DOI: 10.1007/BF00280883. View

17.

Eckerson H, Wyte C, La Du B . The human serum paraoxonase/arylesterase polymorphism. Am J Hum Genet. 1983; 35(6):1126-38. PMC: 1685985. View

18.

Lavie L . Sleep-disordered breathing and cerebrovascular disease: a mechanistic approach. Neurol Clin. 2005; 23(4):1059-75. DOI: 10.1016/j.ncl.2005.05.005. View

19.

Makino S, Handa H, Suzukawa K, Fujiwara M, Nakamura M, Muraoka S . Obstructive sleep apnoea syndrome, plasma adiponectin levels, and insulin resistance. Clin Endocrinol (Oxf). 2006; 64(1):12-9. DOI: 10.1111/j.1365-2265.2005.02407.x. View

20.

Suzuki Y, Jain V, Park A, Day R . Oxidative stress and oxidant signaling in obstructive sleep apnea and associated cardiovascular diseases. Free Radic Biol Med. 2006; 40(10):1683-92. PMC: 1995030. DOI: 10.1016/j.freeradbiomed.2006.01.008. View